Bio Solution Co.,Ltd. (KOSDAQ:086820)
11,990
+890 (8.02%)
At close: Apr 30, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 309.39 billion as of April 30, 2026. Its market cap has increased by 53.86% in one year.
Market Cap
309.39B
Enterprise Value
328.21B
Revenue
15.20B
Ranking
n/a
PE Ratio
1,131.82
Stock Price
11,990.00
Market Cap Chart
Since August 20, 2018, Bio Solution's market cap has increased from 218.31B to 309.39B, an increase of 41.72%. That is a compound annual growth rate of 4.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 286.43B | 49.80% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| S.Biomedics | 424.81B |
| Kangstem Biotech | 386.56B |
| Y-Biologics | 371.10B |
| curacle co.,ltd. | 353.43B |
| NIBEC | 314.32B |
| TiumBio | 308.23B |
| ViGenCell | 229.80B |
| Genome & Company | 227.15B |